Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Seizures can precede cognitive symptoms in late-onset Alzheimer's disease.

Picco A, Archetti S, Ferrara M, Arnaldi D, Piccini A, Serrati C, di Lorenzo D, Morbelli S, Nobili F.

J Alzheimers Dis. 2011;27(4):737-42. doi: 10.3233/JAD-2011-110896.

PMID:
21876255
2.

Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment.

Dimou E, Booij J, Rodrigues M, Prosch H, Attems J, Knoll P, Zajicek B, Dudczak R, Mostbeck G, Kuntner C, Langer O, Bruecke T, Mirzaei S.

Curr Alzheimer Res. 2009 Jun;6(3):312-9. Review.

PMID:
19519314
3.

Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation.

Singleton AB, Hall R, Ballard CG, Perry RH, Xuereb JH, Rubinsztein DC, Tysoe C, Matthews P, Cordell B, Kumar-Singh S, De Jonghe C, Cruts M, van Broeckhoven C, Morris CM.

Brain. 2000 Dec;123 Pt 12:2467-74.

PMID:
11099448
4.

Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein.

Shimada H, Ataka S, Tomiyama T, Takechi H, Mori H, Miki T.

Dement Geriatr Cogn Disord. 2011;32(1):45-54. doi: 10.1159/000330017. Epub 2011 Aug 13.

PMID:
21846988
5.

Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study.

Babiloni C, Benussi L, Binetti G, Bosco P, Busonero G, Cesaretti S, Dal Forno G, Del Percio C, Ferri R, Frisoni G, Ghidoni R, Rodriguez G, Squitti R, Rossini PM.

Neuroimage. 2006 Feb 1;29(3):948-64. Epub 2005 Oct 6.

PMID:
16213753
6.

Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

Drzezga A, Grimmer T, Riemenschneider M, Lautenschlager N, Siebner H, Alexopoulus P, Minoshima S, Schwaiger M, Kurz A.

J Nucl Med. 2005 Oct;46(10):1625-32.

7.

Alzheimer's disease families with amyloid precursor protein mutations.

Rossor MN, Newman S, Frackowiak RS, Lantos P, Kennedy AM.

Ann N Y Acad Sci. 1993 Sep 24;695:198-202. Review.

PMID:
8239283
8.

Amyloid imaging in early detection of Alzheimer's disease.

Nordberg A.

Neurodegener Dis. 2010;7(1-3):136-8. doi: 10.1159/000289223. Epub 2010 Mar 3.

PMID:
20197692
9.

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC.

Brain. 2007 Nov;130(Pt 11):2837-44. Epub 2007 Oct 10.

PMID:
17928318
10.

Mild cognitive impairment--an early stage of Alzheimer's disease?

Almkvist O, Basun H, Bäckman L, Herlitz A, Lannfelt L, Small B, Viitanen M, Wahlund LO, Winblad B.

J Neural Transm Suppl. 1998;54:21-9. Review.

PMID:
9850912
11.

Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years.

Mondadori CR, Buchmann A, Mustovic H, Schmidt CF, Boesiger P, Nitsch RM, Hock C, Streffer J, Henke K.

Brain. 2006 Nov;129(Pt 11):2908-22. Epub 2006 Sep 29.

PMID:
17012294
12.

Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.

van der Vlies AE, Koedam EL, Pijnenburg YA, Twisk JW, Scheltens P, van der Flier WM.

Psychol Med. 2009 Nov;39(11):1907-11. doi: 10.1017/S0033291709005492. Epub 2009 Apr 1.

PMID:
19335933
13.

Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.

Craft S, Teri L, Edland SD, Kukull WA, Schellenberg G, McCormick WC, Bowen JD, Larson EB.

Neurology. 1998 Jul;51(1):149-53.

PMID:
9674794
14.

[Autosomal dominant Alzheimer's disease. Study of a Moroccan family].

Asri F, Moussaoui D, Kadri N.

Encephale. 2003 May-Jun;29(3 Pt 1):254-8. French.

PMID:
12876550
15.

Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.

Palmer K, Di Iulio F, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Spalletta G.

J Alzheimers Dis. 2010;20(1):175-83. doi: 10.3233/JAD-2010-1352.

PMID:
20164594
16.

Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.

García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.

J Alzheimers Dis. 2011;24(3):421-54. doi: 10.3233/JAD-2011-101635.

PMID:
21297257
17.

Conversion from preclinical to dinical stage of Alzheimer's disease as shown by decline of cognitive function in carriers of the Swedish APP-mutation.

Almkvist O, Axelman K, Basun H, Wahlund LO, Lannfelt L.

J Neural Transm Suppl. 2002;(62):117-25.

PMID:
12456057
18.

Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.

Ohm TG, Scharnagl H, März W, Bohl J.

Acta Neuropathol. 1999 Sep;98(3):273-80.

PMID:
10483785
19.

Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.

Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Hartikainen P, Hänninen T, Ryynänen M, Riekkinen PJ.

Neurology. 1996 Feb;46(2):413-9.

PMID:
8614504
20.

CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease.

Perneczky R, Tsolakidou A, Arnold A, Diehl-Schmid J, Grimmer T, Förstl H, Kurz A, Alexopoulos P.

Neurology. 2011 Jul 5;77(1):35-8. doi: 10.1212/WNL.0b013e318221ad47. Epub 2011 Jun 22.

PMID:
21700579

Supplemental Content

Support Center